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Summary 26 
 27 
For a long time tyrosine phosphorylation has been recognized as a crucial post 28 
translational regulatory mechanism in eukaryotes. However, only in the past decade 29 
has recognition been given to the crucial importance of bacterial tyrosine 30 
phosphorylation as an important regulatory feature of pathogenesis. This study 31 
describes the effect of tyrosine phosphorylation on the activity of a major virulence 32 
factor of the pneumococcus, the autolysin LytA, and a possible connection to the 33 
Streptococcus pneumoniae capsule synthesis regulatory proteins (CpsB, CpsC & 34 
CpsD). We show that in vitro pneumococcal tyrosine kinase, CpsD, and the protein 35 
tyrosine phosphatase, CpsB, act to phosphorylate and dephosphorylate LytA. 36 
Furthermore, this modulates LytA function in vitro with phosphorylated LytA binding 37 
more strongly to the choline analogue DEAE.  A phospho-mimetic (Y264E) mutation 38 
of the LytA phosphorylation site displayed similar phenotypes as well as an enhanced 39 
dimerization capacity.  Similarly, tyrosine phosphorylation increased LytA amidase 40 
activity, as evidenced by a turbidometric amidase activity assay. Similarly, when the 41 
phospho-mimetic mutation was introduced in the chromosomal lytA of S. 42 
pneumoniae, autolysis occurred earlier and at an enhanced rate. This study thus 43 
describes to our knowledge the first functional regulatory effect of tyrosine 44 
phosphorylation on a non-capsule related protein in the pneumococcus, and suggests a 45 
link between the regulation of LytA-dependent autolysis of the cell, and the 46 
biosynthesis of capsular polysaccharide.  47 
  48 
Introduction 49 
 50 
Tyrosine phosphorylation is rapidly becoming a major focus of bacterial research, 51 
with studies illustrating its critical link to bacterial pathogenicity (Standish & Morona, 52 
2014; Whitmore & Lamont, 2012). Indeed, we have been amongst those showing a 53 
link, with our long interest in the role of bacterial tyrosine kinase (BY-Kinase) CpsD 54 
and protein tyrosine phosphatase (PTP) CpsB in the regulation of capsule synthesis in 55 
the major human pathogen, Streptococcus pneumoniae, and as a novel target for the 56 
development of antimicrobials (Byrne et al., 2011; Ericsson et al., 2012; Morona et 57 
al., 2000; Morona et al., 2002; Morona et al., 2006; Standish et al., 2012; Standish et 58 
al., 2013). However, we are also interested in whether tyrosine phosphorylation plays 59 
roles outside the capsule biogenesis, regulating the function of various proteins via 60 
specific tyrosine phosphorylation.  61 
 62 
Since early last century, the pneumococcus has been recognized to possess a 63 
characteristic autolysis induced during the stationary phase of growth (Goebel & 64 
Avery, 1929). This has since been shown to be caused by the product of the lytA gene, 65 
a N-acetylmuramoyl L-alanine amidase (Garcia et al., 1985). LytA belongs to a 66 
family of proteins known as choline binding proteins (CBP) (Rosenow et al., 1997), 67 
which while having diverse functions all share the ability to bind phosphorylcholine 68 
residues present in the pneumococcal cell wall (Rosenow et al., 1997). For LytA, 69 
binding to choline is essential for its amidase activity. LytA resides in the cytoplasm 70 
in the inactive E-form, with binding to choline present in the cell wall (Giudicelli & 71 
Tomasz, 1984), and subsequent dimerization, resulting in formation of the C-form 72 
which possesses functional amidase activity. The structure of the choline binding 73 
domain of LytA has illustrated that it contains a total of 6 choline binding repeats, 74 
which are characteristic of CBPs, along with a  total of 4 choline binding sites (Fig. 1) 75 
(Fernandez-Tornero et al., 2001; Fernandez-Tornero et al., 2002). Unlike other CBPs, 76 
LytA does not possess a signal sequence, and to date it is unknown how it translocates 77 
to the cell wall, in order to bind phosphorylcholine and hydrolyse the cell wall. 78 
 79 
The exact role of LytA in S. pneumoniae physiology is still unclear, with some 80 
suggestion that it is required for the release of the toxin pneumolysin (Martner et al., 81 
2008), as well as contributing to bacterial fractricide (Eldholm et al., 2009). However, 82 
while its function is still debated, it is recognized as a virulence factor, with mutation 83 
resulting in decreased ability to cause disease in in vivo models (Berry & Paton, 2000; 84 
Dalia & Weiser, 2011).  85 
 86 
A recent study on the phosphoproteome of S. pneumoniae identified LytA as one of 87 
12 proteins phosphorylated on tyrosine (Sun et al., 2010). With CpsD the only BY-88 
kinase identified to date in S. pneumoniae, and both proteins known to localize to the 89 
cell septum (Henriques et al., 2011; Mellroth et al., 2012), we hypothesized that CpsD 90 
plays a role in the phosphorylation of LytA, and that phosphorylation regulates its 91 
amidase activity. This study shows for the first time an effect of tyrosine 92 
phosphorylation on protein function in S. pneumoniae encoded outside of the capsule 93 
locus, and provides a hitherto unidentified link between cell autolysis and capsular 94 
polysaccharide biosynthesis. 95 
  96 
Methods 97 
Growth media and growth conditions 98 
S. pneumoniae strains (listed in Table 1) were routinely grown in Todd-Hewitt broth 99 
with 1% Bacto yeast extract (THY)  or C+Y (McAllister et al., 2004) at 37°C as 100 
indicated or on Columbia Blood Agar plates supplemented with 5% (v/v) horse blood 101 
and grown at 37°C in 5% CO2. Broth cultures were grown at 37°C without aeration. 102 
E. coli cultures were grown in LB at 37°C with aeration. Antibiotics were used at the 103 
following concentrations: E. coli; Ampicilin 100 µg/ml, Erythromycin 500 µg/ml; S. 104 
pneumoniae: Erythromycin 0.2 µg/ml, Streptomycin 150 µg/ml, Kanamycin 200 105 
µg/ml. 106 
 107 
DNA methods and E. coli transformation 108 
E.coli K-12 DH5α was used for all cloning. DNA manipulation, PCR, and 109 
transformation into E.coli were performed as previously described (Morona et al., 110 
1995).  111 
 112 
Protein purification 113 
LytA was purified essentially as described previously (Romero et al., 2007). Briefly, 114 
overnight cultures of the indicated strain were pelleted, washed in 20 mM phosphate 115 
buffer pH 7, and lysed at > 1000 PSI via a French Pressure cell. Insoluble material 116 
was removed by ultracentrifugation (150,000 × g for 1 hr) and isolated soluble 117 
fractions incubated with DEAE Sepharose Fastflow (GE Healthcare) for 1 hr at room 118 
temperature. DEAE Sepharose was washed three times in 20 mM phosphate buffer 119 
pH 7.0 supplemented with 1.5 mM NaCl. LytA was then eluted from DEAE 120 
Sepharose  with 20 mM phosphate buffer pH 7 with 2% (w/v) choline chloride. The 121 
purity of eluted LytA was confirmed as > 95% by SDS-PAGE, and LytA was stored 122 
at - 20 °C either with or without dialysis in 50 mM Phosphate buffer pH 7.0. For 123 
analysis of LytA purified from DH5α containing pGL80 and pCpsCD, the protein was 124 
washed using Amicon Ultra-4 centrifugal filter units and resuspended in 50 mM 125 
phosphate buffer without choline and NaCl. Protein estimation was carried out using 126 
BCA Kit (ThermoFisher).  CpsB was purified as previously described (Standish et al., 127 
2012). 128 
 129 
Construction of amino acid substitutions in LytA 130 
Tyrosine 264 of LytA in pGL80 was mutated to Phenylalanine (Oligonucleotides 131 
AS95, AS96), Glutamate (AS97, AS98), and Alanine (AS99, AS100) using the 132 
QuikChange Lightning Site Directed Mutagenesis Kit® (Stratagene) according to the 133 
manufacturer’s instructions. Mutational alterations were confirmed by DNA 134 
sequencing. 135 
 136 
Antibody production 137 
In order to produce antibodies against LytA and CpsB, purified protein (≥ 95 % as 138 
judged by Coomassie stained SDS-PAGE) was supplied to IMVS, Veterinary 139 
Services, Gilles Plain SA, Australia where polyclonal antibody was produced in 140 
rabbits.   αLytA recognizes all variants of LytA described here with equal efficiency, 141 
as determined by comparing Western immunoblots with αLytA with Coomassie 142 
Brilliant Blue stained SDS-PAGE analysis (data not shown). 143 
 144 
Construction of LytA amino acid substitutions in S. pneumoniae D39. 145 
To construct point mutations within lytA, first the Janus cassette (Sung et al., 2001) 146 
was inserted into the lytA gene using overlap extension PCR. The 5’ region of lytA 147 
was amplified with  AS117 + AS101, a 3’ region with AS118 + AS102 and the Janus 148 
cassette with AS113 + AS114. These PCR products were then combined in a second 149 
round of PCR with AS101 and AS102.  Overlap product was then transformed into a 150 
Streptomycin resistant (StrepR) D39 strain (D39S), which was made resistant by 151 
transformation with a PCR product of rpsL from StrepR Rx1. Transformants were 152 
selected on the basis of Kanamycin resistance, and Streptomycin sensitivity, and 153 
confirmed by sequencing. 154 
  155 
LytA was mutated using overlap PCR using the following combination of 156 
oligonucleotides for 5’ and 3’ regions of lytA containing the relevant mutation;Y264F: 157 
AS101 + AS95, AS102 +AS96; Y264E: AS97 +AS101, AS102 + AS98; Y264A: 158 
AS101 + AS99. The original PCR products were then combined in a second round of 159 
PCR using AS101 and AS102 and transformed into D39 LytAJanus, and StrepR 160 
colonies selected for. Mutations were confirmed by sequencing.  Transformations 161 
were carried out as described previously (Standish et al., 2005). 162 
 163 
LytA Binding Assays 164 
In order to investigate affinity of LytA to the choline analogue DEAE (DEAE 165 
sepharose fast flow – GE Healthcare Life Sciences), 500 µl of 0.2 mg/ml of soluble 166 
lysate from the indicated E. coli strain was incubated with 20 µl of DEAE Sepharose 167 
for 10 mins while rotating at room temperature. DEAE was then washed in 50 mM 168 
phosphate buffer pH 7.0 with 1.5 M NaCl × 3 and subsequently resuspended in 2 × 169 
sample buffer, and amount of LytA present analyzed by Coomassie Brilliant Blue 170 
staining of the SDS-PAGE gel. 171 
 172 
Construction of pCpsCD 173 
For the BY-kinase CpsD to be active it requires the polysaccharide co-polymerase 174 
protein, or kinase adaptor membrane protein, CpsC (Bender & Yother, 2001). In, S. 175 
aureus fusion of the C-terminal cytoplasmic region of this homologous protein to the 176 
BY-kinase results in an active protein (Olivares-Illana et al., 2008; Soulat et al., 2006) 177 
We hypothesized this would also be the case in S. pneumoniae. Therefore, we fused 178 
D202-K230 of Cps4C(SP_0348) (the predicted C-terminal cytoplasmic region) to 179 
Cps4D (SP_0349) by overlap PCR.  Originally we amplified D202-K230 of Cps4C 180 
with AS1 and AS2 and Cps4D with AS3 and AS4. These products were then 181 
combined in a second round of PCR and amplified with AS1 and AS4. This PCR 182 
product was ligated into pGEMT-Easy (Promega). Oligonucleotides AS68 and AS77 183 
(Table 1) were used to amplify the DNA sequence and this PCR product then cloned 184 
into pAL2 (Beard et al., 2002) with the lux operon deleted, as described previously 185 
(Trappetti et al., 2011). Transformant of E. coli DH5α containing the plasmid 186 
(pCpsCD) was confirmed by PCR and sequencing.  187 
 188 
SDS-PAGE and Western immunoblot 189 
Proteins were separated on 12% SDS-PAGE as previously described (Laemmli, 1970) 190 
using low molecular weight marker (Amersham). For Western immunoblot samples 191 
were transferred to either Immobilon-P (Millipore) (αPY; PY-20 - Santa Cruz 192 
Biotechnology), or Nitrobind (GE Water and Process Technologies) (α-LytA). 193 
Membranes were probed with primary antibody overnight and after washes incubated 194 
as appropriate with either horseradish peroxidase-conjugated goat anti-rabbit or goat 195 
anti-mouse secondary antibodies (Biomediq DPC) for 2 h. The membrane was then 196 
incubated with chemiluminescence blotting substrate (Sigma) for 5 min, followed by 197 
exposure of the membrane to X-ray film (Agfa). The film was developed using a 198 
Curix 60 automatic X-ray film processor (Agfa) or imaged with a Kodak Image 199 
Station 4000MM Pro (Carestream Molecular Imaging) to visualize the reactive bands. 200 
 201 
Non-denaturing PAGE 202 
Non-denaturing PAGE was undertaken essentially as for SDS-PAGE, but with SDS 203 
omitted from all steps, including the PAGE, Running buffer, and the 2 × Sample 204 
buffer. 12 % Gels were electrophoresed at 120V at 4°C, and stained with Coomassie 205 
Brilliant Blue. 206 
 207 
Turbidometric amidase activity assay. Amidase activity was analyzed by measuring 208 
the decrease in turbidity of D39 LytAJanus (Table 1) cells after incubation with 209 
purified LytA proteins, essentially as described previously (Mellroth et al., 2014). 210 
D39 LytAJanus was grown to OD600 ≈ 0.5 in THY, then pelleted by centrifugation, 211 
washed twice in PBS and stored at -20 °C in PBS until use. In order to measure 212 
specific activity, thawed cells were equilibrated to OD600 ≈ 1.0 and distributed into 213 
wells. They were then incubated with either 2 µg/ml-1 purified protein or 250 µg/ml-1 214 
of respective cell lysates. The initial rate of decrease in turbidity was determined for 215 
each protein, and their relative activities were calculated compared to the wt control. 216 
Results for purified proteins and cell lysates are from 2 and 3 independent 217 
experiments respectively.  218 
 219 
Growth Curves 220 
For growth curves, S. pneumoniae were taken from Blood Agar plates incubated for 221 
18 h at 37°C in 5% CO2, and inoculated into THY and grown till mid-log phase 222 
(OD600 ≈ 0.5). Bacteria were then sub-cultured 1/20 into C+Y and incubated at 37°C 223 
in 96 well tray covered with Breath Easy® membrane (Sigma) in Powerwave XS 224 
(Biotek). A600 readings were taken every 30 min for the indicated time period. Rate of 225 
autolysis was determined by comparing the fastest rate of autolysis in each strain over 226 
a 1 hr time period. The results are represented as % of the wt. Results are from 4 227 
separate experiments, with each experiment performed at least in duplicate. 228 
 229 




LytA is tyrosine phosphorylated on Y264 by CpsD and dephosphorylated by 234 
CpsB 235 
A recent report on the phosphoproteomic profile of Streptococcus pneumoniae D39 236 
(Sun et al., 2010) identified the autolysin, LytA, as being tyrosine phosphorylated on 237 
Y264. As we have investigated the role of the tyrosine phospho-regulatory system 238 
CpsBCD in the regulation of capsule biosynthesis (Byrne et al., 2011; Morona et al., 239 
2000; Morona et al., 2002; Morona et al., 2004; Morona et al., 2006; Standish et al., 240 
2012), we hypothesized that this system may directly influence the level of tyrosine 241 
phosphorylation of the autolysin LytA, as to date no other BY-kinases have been 242 
described in the pneumococcus (Morona et al., 2000). Thus, we hypothesized that 243 
CpsD is responsible for tyrosine phosphorylation of LytA. In order to investigate this, 244 
we constructed a fusion comprising the C-terminal cytoplasmic portion of CpsC 245 
(D202-K230), which is required for CpsD activity, and full length CpsD in the vector 246 
pAL2 (Beard et al., 2002) as described in the Materials and Methods. This was based 247 
on previous work undertaken on homologous proteins in S. aureus (Olivares-Illana et 248 
al., 2008). When this this plasmid (pCpsCD) was transformed into DH5α, we noticed 249 
that hyper phosphorylation occurred indicating that the kinase was active (Fig. 2a). 250 
Thus, we transformed pCpsCD  together with a plasmid encoding LytA (pGL80) into 251 
DH5α (Garcia et al., 1986), and purified LytA. LytA purified from this strain (LytA-252 
P) as described in Materials and Methods had higher levels of phosphorylation 253 
compared to LytA from control strain containing vector alone, suggesting CpsD can 254 
phosphorylate LytA (Fig. 2b, lanes 1 & 2).   255 
 256 
Sun et al. (2010) (Sun et al., 2010) reported that LytA was phosphorylated on 257 
Tyrosine 264 (Fig. 1a). To confirm this finding we mutated this tyrosine to a 258 
phenylalanine. Purification of this protein from a strain also containing pCpsCD 259 
yielded LytAY264F which reacted weakly with αPTyr, similar to wt LytA when 260 
purified from a strain lacking pCpsCD (Fig. 2b). This suggests that Tyrosine 264 is 261 
the primary residue phosphorylated by CpsCD. 262 
 263 
In order to investigate if the PTP CpsB can act on LytA-P, purified LytA-P (from E. 264 
coli DH5α containing pGL80 and pCpsCD) was incubated with purified CpsB and the 265 
level of tyrosine phosphorylation investigated by Western immunoblotting (Fig. 2c). 266 
Incubation with CpsB decreased phosphorylation by approximately 90% suggesting 267 
the PTP can de-phosphorylate LytA-P. Thus, this data suggested that the capsule 268 
regulatory proteins CpsB and CpsD may play a role in LytA phosphorylation. 269 
 270 
 271 
LytA Tyrosine phosphorylation enhances binding of LytA to choline analogue 272 
DEAE 273 
As Y264 is hypothesized to play a role in the affinity of LytA to choline, we 274 
investigated the ability of LytA, LytA-P, and LytAY264F-P in E. coli derived soluble 275 
protein fractions to bind DEAE, the choline analogue utilized to purify the autolysin. 276 
As well as being a useful method for easily purifying LytA, DEAE has been shown to 277 
result in conversion of LytA to the active E-form at similar concentrations to choline 278 
(Sanz et al., 1988). We first confirmed that LytA (lane 1), LytA-P (lane 2), and 279 
LytAY264F-P (lane 3) were present in the lysates at the same level (Fig. 3a). Then, we 280 
incubated lysates with DEAE-Sepharose, and investigated LytA binding by SDS-281 
PAGE and Coomassie Blue staining. LytA-P was detected at approximately 1.6 fold 282 
higher levels than LytA (lane 1 vs lane 2) (Fig. 3b & 3c). Furthermore, LytAY264F-P 283 
bound at a similar level to LytA (lane 1 vs lane 3), suggesting specific 284 
phosphorylation of Y264 enhanced binding to DEAE.   285 
  286 
In order to further confirm the specific effects of phosphorylation of Y264, a 287 
phospho-mimetic substitution was also constructed (LytAY264E). In order to control for 288 
the change in size of the residue, we also constructed a control mutation (LytAY264A). 289 
Investigation using Phyre2 suggested that these mutations would not influence the 290 
secondary structure of the protein (Kelley & Sternberg, 2009). Furthermore, the 291 
stability of all proteins was investigated by limited proteolysis and were similar to the 292 
wild-type protein (data not shown). 293 
 294 
Incubation of the lysates of containing these proteins with DEAE showed results 295 
which mirrored those seen with LytA and LytA-P. The phospho-mimetic mutation 296 
(LytAY264E; lane 2) enhanced affinity to DEAE while the phospho-ablative mutation 297 
(LytAY264A; lane 3) was less than the wt control (lane 1) (Fig. 4b & 4c). Thus, this 298 
provided further evidence that it is specifically the tyrosine phosphorylation of Y264 299 
which is responsible for the increased affinity. 300 
 301 
Phosphorylation modulates LytA dimerization  302 
The purification of LytA as described in the Materials and Methods relies on the 303 
affinity of the amidase to choline, and thus this method purifies the C-form or active 304 
form of the enzyme. When we separated the LytA protein on non-denaturing PAGE in 305 
order to investigate their native oligomeric conformation, in all cases a single band 306 
was present. The C-form of LytA is dimeric (Fernandez-Tornero et al., 2001), and 307 
thus we reasoned that this band represents the dimeric form of the protein (Fig. 5a). 308 
We hypothesised that as LytAY264E had increased affinity to choline, it would show an 309 
increased ability to retain its dimeric form when choline was removed by dialysis. We 310 
thus undertook dialysis in 50 mM phosphate buffer pH 7.4 and used non-denaturing-311 
PAGE to assess the oligomeric state of LytA. Consistently we saw that LytAY264E 312 
retained the higher order oligomeric state to a greater level than the wt, LytAY264F or 313 
LytAY264A (Fig. 5a & 5b). Separation of the proteins post dialysis on denaturing SDS-314 
PAGE resulted in one band for each LytA variant (Fig. 5c).  Addition of choline 315 
resulted in only one band again being visible on the non-denaturing PAGE (data not 316 
shown). Thus, this suggested LytAY264E had an increased ability to retain the dimeric 317 
form during dialysis. This provided further confirmation that LytAY264E substitution 318 
increased affinity to choline which is essential for LytA dimerization. 319 
 320 
Tyrosine phosphorylation increases LytA Amidase activity  321 
As tyrosine phosphorylation of LytA increased affinity to choline, and the ability of 322 
LytA to dimerise, we reasoned this may also enhance LytA amidase activity. In order 323 
to investigate this, we utilised a turbidometric amidase activity assay as described in 324 
the materials and methods. First, we utilized purified proteins of the different LytA 325 
forms to investigate activity. However, no significant differences were apparent 326 
between the strains (Fig. 6a). We hypothesized that this was due to the fact that the 327 
enzymes had already undergone the “conversion” process of pneumococcal amidases, 328 
; the proteins were purified by elution with 2 % choline, and thus would already be 329 
converted into the C-form. 330 
Thus, in order to investigate amidase activity prior to the conversion process, we used 331 
cell lysates containing LytA, as the proteins were present in lysates at equal levels 332 
(Fig. 3a & 4a). These would contain LytA in the inactive E-form, as they had not 333 
been converted by binding to choline or a choline analogue. The control strain, DH5α 334 
containing vector alone, led to only minimal decrease in turbidity of D39LytAJANUS 335 
(approximately 10% of the wild-type control). LytA-P had 215% of wildtype activity, 336 
with this increase lost in LytAY264F-P (Fig. 6b). Similarly, phospho-mimetic 337 
substitution of LytA (LytAY264E) had increased activity, while the phospho-ablative 338 
mutation did not. Thus, this data suggested phosphorylation of Y264 results in 339 
increased LytA conversion capacity likely through increasing capacity to bind 340 
choline. 341 
 342 
Chromosomal mutation of Y264 alters autolysis of S. pneumoniae 343 
As in vitro we had seen that phosphorylation of LytA, and phospho-ablative mutation 344 
altered the activity of LytA, we were interested to see whether this effect would be 345 
evident in S. pneumoniae. Thus, we constructed S. pneumoniae D39 mutants 346 
expressing chromosomally encoded LytA with phospho-ablative (D39LytAY264F; 347 
D39LytAY264A) and phospho-mimetic (D39LytAY264E) mutations as described in the 348 
Materials and Methods. These strains had similar levels of LytA, as determined by 349 
Western immunoblotting (Fig. 7a). We then investigated the growth of these strains 350 
over an extended length of time in C+Y. During logarithmic growth, there was no 351 
apparent difference in growth (Fig. 7b). However, consistently, the strain with the 352 
phospho-ablative mutation (D39LytAY264F) showed a prolonged time to lysis 353 
compared to the wt. Conversely, the strain with the phospho-mimetic mutation 354 
(D39LytAY264E) showed an earlier onset of autolysis. The strain with the additional 355 
control mutation (D39LytAY264A) was similar to the wt. When we compared the rate 356 
of autolysis of the strain by comparing the slope of lysis, we saw that the phospho-357 
mimetic mutation led to a significant increase in the rate of autolysis, with this 358 
significantly different from other strains (Fig. 7c).  Thus, these results suggest that 359 
tyrosine phosphorylation of LytA on Y264 enhances activation of LytA activity in S. 360 
pneumoniae.  361 
Discussion 362 
This is the first study to our knowledge to describe tyrosine phosphorylation as a 363 
regulator of non-capsule related protein function in the major human pathogen 364 
Streptococcus pneumoniae.  Furthermore, with the only pneumococcal BY-kinase 365 
found to date the key capsule regulator CpsD (Morona et al., 2000), it seems possible 366 
that regulation of capsule and LytA activity is linked. Indeed, we have shown CpsD, 367 
as well as pneumococcal PTP CpsB, can act on LytA as a substrate in vitro, although 368 
as yet we have been unable to detect this in situ, likely due to low levels of LytA 369 
tyrosine phosphorylation. Previous studies illustrated that LytA as well as CpsD and 370 
BY-kinase adaptor protein CpsC locate to the septa of S. pneumoniae (De Las Rivas 371 
et al., 2002; Henriques et al., 2011; Mellroth et al., 2012), suggesting the possibility 372 
that these proteins co-localize, further suggestive of a link between capsular 373 
polysaccharide synthesis and autolysis.   374 
 375 
Sun et al. recently performed a phosphoproteomic study of the pneumococcus in 376 
which they showed that Y264 of LytA was phosphorylated (Sun et al., 2010). We 377 
have confirmed this finding, showing that this is the predominant site of 378 
phosphorylation. LytA is comprised of two distinct domains, an N-terminal domain 379 
responsible for the N-acetyl muramyl amidase activity, and a C-terminal choline 380 
binding domain, responsible for the ability of LytA to bind to phosphorylcholine 381 
residues present in the cell wall. Y264 is present in C-terminal choline binding 382 
domain within Choline Binding Repeat 4. Indeed, it has been suggested that this 383 
residue is important for the binding of choline (Fig. 1a & 1b) (Fernandez-Tornero et 384 
al., 2002). While there is significant homology between the ChBRs, Y264 is the only 385 
tyrosine at this particular site.  386 
  387 
 388 
The forces responsible for the binding of the choline in the family of CBPs are the 389 
same in all cases. While one component is hydrophobic, another is electrostatic, a 390 
cation-π interaction between the electron-rich systems of aromatic rings and the 391 
positive charge of the choline (Fernandez-Tornero et al., 2001). We hypothesized that 392 
the increased negative charge of phosphorylation at Y264 may be important for the 393 
binding of LytA to phosphorylcholine, and regulation of its subsequent amidase 394 
activity, and thus set out to investigate this. 395 
 396 
We showed that tyrosine phosphorylation increased the affinity of LytA to the choline 397 
analogue DEAE-Sepharose. Furthermore, these affects were largely prevented by 398 
phospho-ablative substitution (LytAY264F). Thus, this suggested that specific 399 
phosphorylation of Y264 was responsible for this increase in affinity. Additionally, 400 
phospho-mimetic substitution (LytAY264E) also showed increased affinity to DEAE-401 
Sepharose, while the corresponding control (LytAY264A) did not, further supporting 402 
our observations.  403 
 404 
In the cytoplasm, LytA resides in the inactive E-form, with the protein in the 405 
monomeric state (Tomasz & Westphal, 1971). Conversion to the catalytically active 406 
C-form occurs following interaction with phosphoryl-choline in the cell wall, 407 
resulting in subsequent LytA dimerization. While conversion and dimerization are 408 
different processes, it is still not known whether conversion can only occur following 409 
the formation of the dimer (Romero et al., 2007). Our analysis of the oligomeric state 410 
of the LytA protein following dialysis, suggested that the phospho-mimetic form 411 
(LytAY264E) retain its dimeric state to a greater extent than the wild-type and phospho-412 
ablative forms (LytAY264F & LytAY264A), which correlates with an increased affinity to 413 
choline. Furthermore, we also showed that this correlated with a difference in the 414 
overall activity of the enzyme. Interestingly, when we used purified proteins, having 415 
already undergone conversion due to the purification process, there were no 416 
significant amidase activity differences between the proteins (Fig. 6a). This provides 417 
evidence that we have not affected the secondary structures of the proteins through 418 
mutation or phosphorylation, as they still possess the same activity when bound to 419 
choline. However, when we used E. coli soluble cell lysates, in which LytA had not 420 
undergone previous conversion, significant differences were evident (Fig. 6b). 421 
Phosphorylation of Y264 enhanced LytA amidase activity, likely due to an increased 422 
capacity to bind choline and undergo the conversion to the C-form. 423 
 424 
In order to confirm that this in vitro phenomenon played a role in vivo, we constructed 425 
LytA phospho-ablative and phospho-mimetic mutations in lytA on the chromosome of 426 
S. pneumoniae D39. The phospho-ablative substitution, D39LytAY264F, showed 427 
prolonged time to lysis compared to the isogenic wt, suggestive that phosphorylation 428 
was occurring on the wt LytA in order to promote autolysis. Furthermore, the strain 429 
with the phospho-mimetic (D39LytAY264E) substitution showed an earlier onset of 430 
autolysis. Additionally, by comparison of the slope of lysis, it was evident that the 431 
phosphomimetic mutation led to an increased autolytic capability, correlating with our 432 
in vitro results.  Thus, this data suggested that phosphorylation was responsible for 433 
both an earlier onset, and faster autolysis phase. 434 
 435 
While LytA was originally postulated to be always situated in the cell wall, in recent 436 
times evidence has emerged suggesting LytA is located in the cytoplasm until the 437 
membrane is disrupted and the protein is able to gain access to peptidoglycan and 438 
cause the cell to undergo autolysis (Mellroth et al., 2012). Such a model, which seems 439 
likely, would suggest that no regulation mechanism is required. However, our work 440 
showed that phospho-mimetic and phospho-ablative mutations on the chromosome of 441 
the pneumococcus altered the time to autolysis in whole cell pneumococci, suggesting 442 
LytA tyrosine phosphorylation may alter the process whereby LytA gains access to its 443 
substrate. This may contribute in vivo to the numerous roles that LytA plays, such as 444 
in bacterial fractricide, release of pneumolysin and the control of bacterial size.  445 
 446 
With LytA a member of the of the CBP family in S. pneumoniae, it is interesting to 447 
speculate whether other CBPs in the pneumococcus whose affinity for choline are 448 
affected by tyrosine phosphorylation in a similar way to LytA. Indeed, another CBP, 449 
CbpC is also phosphorylated on tyrosine, although this phosphorylation does not 450 
occur in the region of the choline binding domain of the protein, and thus its effect on 451 
function is less clear (Sun et al., 2010). Furthermore, LytA is also known to be 452 
phosphorylated on Threonine (Sun et al., 2010), with further work required to 453 
determine whether this affects LytA function.  454 
 455 
Additionally, we are interested in investigating further correlations between the 456 
phosphotyrosine regulatory system and LytA. Previous data has suggested that loss of 457 
capsule has an effect on the sensitivity of the pneumococcus to LytA amidase activity 458 
(Fernebro et al., 2004). With deletion of either the BY-kinase CpsD or PTP CpsB 459 
resulting in strains possessing reduced capsule, this approach will be problematic. 460 
When we expressed the active CpsCD (pCpsCD) fusion in R6, an unencapsulated S. 461 
pneumoniae strain, no obvious effect on growth or lysis was evident (data not shown). 462 
It is possible that absence of the transmembrane section of this protein results in a 463 
protein unable to undergo normal localization. Furthremore, the absence of capsule, 464 
and thus the hyper-sensitivity to LytA may make seeing affects difficult. 465 
Alternatively, other as yet unidentified BY-kinases are present which may affect the 466 
phosphorylation of the LytA. We are currently undertaking further studies to 467 
investigate this in more detail.  468 
 469 
To date, no phosphoproteome of the pneumococcus has concentrated on the discovery 470 
of solely tyrosine phosphorylated proteins. Indeed, the original phosphoproteomic 471 
study on the pneumococcus only found 12 proteins phosphorylated on tyrosine, 472 
although suprisingly auto-phosphorylating tyrosine kinase CpsD was not amongst 473 
these (Sun et al., 2010). Thus, this would suggest that this study likely did not find the 474 
majority of tyrosine phosphorylated proteins. Indeed, a recent study which 475 
concentrated solely on finding phosphorylated tyrosines in E. coli, took the number of 476 
proteins known to be tyrosine phosphorylated in the bacteria from 32 to 342 (Hansen 477 
et al., 2013), suggestive that tyrosine phosphorylation is a likely much under-478 
appreciated form of post-translational regulation in bacteria as a whole, including S. 479 
pneumoniae. With this study illustrating that tyrosine phosphorylation can influence 480 
the activity of a major virulence factor this suggests that tyrosine phosphorylation 481 
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Table 1.  490 
Strain Reference 
E. coli  
DH5α Gibco-BRL 
Plasmid  
pGL80 (Garcia et al., 1986) 
pAL2 (Trappetti et al., 2011) 
pCpsCD This work 
pGL80Y264F This work 
pGL80Y264E This work 
pGL80Y264A This work 
S. pneumoniae  
D39S This work 
D39 LytAJanus This work 
D39 LytAY264F This work 
D39 LytAY264E This work 
D39 LytA Y264N This work 
Oligonucleotide Sequence 
AS95 5’ CTGGGTCAAGTTCAAGGACACTTGG 3’ 
AS96 5’ CCAAGTGTCCTTGAACTTGACCCAG 3’ 
AS97 5’ CTGGGTCAAGGAAAAGGACACTTGG 3’ 
AS98 5’ CCAAGTGTCCTTTTCCTTGACCCAG 3’ 
AS99 5’ CTGGGTCAAGGCAAAGGACACTTGG 3’ 
AS100 5’ CCAAGTGTCCTTTGCCTTGACCCAG 3’ 
AS91 5’ ACAGGAGGACTCTCTatgGACACCCGTGTGAAACGTCCT 3’ 
AS92 5’ GCGCGAATTcttaCTATTTTTTATTTTTCCCGTAATCTCC 3’ 
AS101 5’ TTGACTGTCCTTATTTCATTCCGC 3’ 
AS102 5’ CCTCTCACATTACCCTACATATCG 3’ 
AS1 5’ GCggtaccagGATACTCGTGTGAAACGTCCGG 3’ 
AS2 5’ taatgtcggcatTTTCAACTTACCCAAGTTTGGCAC 3’ 
AS3 5’ ggtaagttgaaaATGCCGACATTAGAAATAGCACAA 3’ 
AS4 5’ GCgagctcTTATTTTTTACCATAATTTCCATAGGA 3’ 
AS68 5’ ACAGGAGGACTCTCTATGGATACTCGTGTGAAACGTCCGG 3’ 
AS77 5’ GCGCGAATTTTATTTTTTACCATAATTTCCATAGGA 3’ 
AS113 5’ CCGTTTGATTTTTAATGGATAATG 3’ 
AS114 5’ AGAGACCTGGGCCCCTTTCC 3’ 
AS117 5’ CATTATCCATTAAAAATCAAACGGATTCTACTCCTTATCAATTAAAACAAC 3’ 
AS118 5’ GGAAAGGGGCCCAGGTCTCTTAATGGAATGTCTTTCAAATCAGAACAG 3’ 
AS120 5’ TGTTCCCAGCTATTTTTATTCAGA 3’ 
AS121 5’ TCTCTTTATCCCCTTTCCTTATGC 3’ 
 491 
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  665 
Figures 666 
Figure 1. Location of Y264 in Choline Binding Repeat of the Choline Binding 667 
Domain of LytA. (a) Choline Binding Repeats of LytA (D39; SPD_1737) showing 668 
site of tyrosine phosphorylation (Y264) present in ChBR4. While there is significant 669 
similarity between repeats, Y264 is the only tyrosine present at this site. (b) 670 
Illustration of the position of Y264 (Red) within the structure of the choline binding 671 
domain of LytA (Pdb: 1GVM) (Fernandez-Tornero et al., 2002). Bound choline 672 
residue is highlighted in green. 673 
 674 
Figure 2. BY-kinase CpsD and PTP CpsB act on LytA. (a) Whole cell lysates from 675 
E. coli DH5α without (1) and with (2) expression of pCpsCD was investigated for 676 
tyrosine phosphorylation via Western immunoblotting. CpsCD is marked, while other 677 
proteins are additional increases in phosphorylation. (b)  LytA (0.1 µg) purified either 678 
without (lane 1) or with (lane 2) co-expression of an active form of CpsD (pCpsCD) 679 
and (lane 3) LytAY264F co-expressed with CpsD were investigated for tyrosine 680 
phosphorylation via Western immunoblotting (αPY). Loading was confirmed by 681 
Coomassie Brilliant Blue stained SDS-PAGE.  (c) CpsB (2 µg) was incubated alone 682 
(lane 1) or with LytA (1 µg) (lane 2) for 1 hr and phosphorylation was investigated by 683 
Western immunobloting with αPY and αLytA.   684 
 685 
Figure 3. LytA phosphorylation increases attachment to DEAE. (a) 10 µg of 686 
soluble protein from E. coli DH5α containing (lane 1) LytA, (lane 2) LytA-P and 687 
(lane 3) LytAY264F-P were separated on SDS-PAGE gel, and subjected to Western 688 
immunoblotting with αLytA. (b) 0.2 mg/ml of each soluble lysate was incubated with 689 
DEAE-Sepharose for 30 min as described in Material and Methods, with bound 690 
protein detected by Coomassie Brilliant Blue staining of the SDS-PAGE gel. 691 
Dilutions of bound proteins samples were electrophoresed (Neat, 1:2 and 1:4) in order 692 
to help estimate differences. (c) Differences were quantified by Image J densitometric 693 
analysis of result from 3 separate experiments. (* - p < 0.05, One-way Anova with a 694 
Tukey Test). 695 
 696 
Figure 4. LytAY264E has increased attachment to DEAE. (a) 10 µg of soluble 697 
protein from E. coli DH5α containing (lane 1) LytA, (lane 2) LytAY264E and (lane 3) 698 
LytAY264A were separated on SDS-PAGE gel, and subjected to Western 699 
immunoblotting with αLytA. (b) 0.2 mg/ml of each soluble lysate was incubated with 700 
DEAE-Sepharose for 30 min as described in Material and Methods, with bound 701 
protein detected by Coomassie Brilliant Blue staining of the SDS-PAGE gel. 702 
Dilutions of bound proteins samples were electrophoresed (Neat, 1:2) in order to help 703 
estimate differences. (c) Differences were quantified by Image J densitometric 704 
analysis of result from 3 separate experiments (*** - p < 0.001, ** - p < 0.01, One-705 
way Anova with a Tukey Test). 706 
 707 
Figure 5. Phosphorylation influences LytA dimerization. (a) LytA (lanes 1 & 5) 708 
and it variants LytAY264F (lanes 2 & 6), LytAY264E (lanes 3& 7) and LytAY264A (lanes 4 709 
& 8) were purified, dialyzed as described in Materials and Methods, and 710 
approximately 2 µg separated by non-dentaturing PAGE. (b) Relative percentages of 711 
the monomer present were determined by Image J densitometric anaylsis of result 712 
from 3 separate experiments (* - p < 0.05, One-way Anova with a Tukey Test). (c) 713 
Dialysed samples were also separated on denaturing SDS-PAGE, and stained with 714 
Coomassie Brilliant Blue. Molecular weights (MW) are indicated in kDa. 715 
 716 
Figure 6. Phosphorylation increases LytA amidase activity. (a) Purified proteins (2 717 
µg/ml) or (b) cell lysates (250 µg/ml) containing (1) LytA, (2) LytA-P, (3)LytAY264F-718 
P, (4) LytAY264E and (5) LytAY264A were compared for LytA amidase activity using a 719 
turbidometric assay as described in Materials and Methods. Results represent Mean ± 720 
SD from 2 (purified proteins) and 3 (cell lysates) independent experiments 721 
respectively. Statistical analysis was undertaken using a One-way Anova with a 722 
Tukey Test (**** - p < 0.0001; ** - p < 0.01). 723 
 724 
Figure 7. Chromosomal  LytA phosphoablative and phosphomimetic 725 
substitutions alter D39 autolysis. (a) Lysates from D39, D39 LytAY264F, D39 726 
LytAY264E and D39 LytAY264A were separated on SDS-PAGE gel and subjected to 727 
Western immunoblotting with αLytA and αCpsB. (b) Strains D39, D39LytAJanus, 728 
D39 LytAY264F, D39 LytAY264E and D39 LytAY264A were grown for indicated time 729 
periods in C+Y with A600 recorded every 30 mins. Result is representative of four 730 
separate experiments. (c) Rate of autolysis was compared as described in Material and 731 
Methods. Statistical analysis was undertaken using a One-way Anova with a Tukey 732 
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